Home > Insider Trading > Filing (0001181431-11-038924)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1070336	Achillion Pharmaceuticals Inc	ACHN	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1378588	Milind Deshpande	C/O Achillion Pharmaceuticals 300 George Street New Haven CT 06511	President And Cso	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2011-06-28	12,500	$1.60	12,500	No	4	M	Direct
Common Stock	Acquisiton	2011-06-28	18,750	$1.60	31,250	No	4	M	Direct
Common Stock	Acquisiton	2011-06-28	13,125	$1.60	44,375	No	4	M	Direct
Common Stock	Acquisiton	2011-06-28	5,313	$1.05	49,688	No	4	M	Direct
Common Stock	Disposition	2011-06-28	44,375	$8.05	5,313	No	4	S	Direct
Common Stock	Disposition	2011-06-28	5,313	$8.50	0	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common	Employee Stock Option (Right to Buy)	Acquisiton	2011-06-28	12,500	$0.00	12,500	$1.60
Common	Employee Stock Option (Right to Buy)	Acquisiton	2011-06-28	18,750	$0.00	18,750	$1.60
Common	Employee Stock Option (Right to Buy)	Acquisiton	2011-06-28	13,125	$0.00	13,125	$1.60
Common	Employee Stock Option (Right to Buy)	Acquisiton	2011-06-28	5,313	$0.00	5,313	$1.05

Remaning Holdings	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
0	2012-12-18	No	4	M	Direct
0	2013-09-10	No	4	M	Direct
0	2014-12-16	No	4	M	Direct
31,887	2018-12-15	No	4	M	Direct

Footnotes

The price in Column 4 is a weighted average price. The actual sale prices for these transactions ranged from $8.00 to $8.83. The reporting person will provide to the issuer, any security holder of the issuer, or the SEC staff, upon request, information regarding the number of shares sold at each price within the range.
This option was granted on December 18, 2002 and vested over a four year period with 25% of the shares vesting on the first anniversary of the date of grant and an additional 6.25% vesting at the end of each three-month period thereafter.
This option was granted on September 10, 2003 and vested over a four year period with 25% of the shares vesting on the first anniversary of the date of grant and an additional 6.25% vesting at the end of each three-month period thereafter.
This option was granted on December 16, 2004 and vested over a four year period with 25% of the shares vesting on the first anniversary of the date of grant and an additional 6.25% vesting at the end of each three-month period thereafter.
This option was granted on December 15, 2008 and vests over a four year period with 25% of the shares vesting on the first anniversary of the date of grant and an additional 6.25% vesting at the end of each three-month period thereafter.